Inhibrx gets EC orphan drug designation for chondrosarcoma therapy

Chondrosarcoma is an orphan bone cancer and around 2,800 new patients per year are diagnosed with the disease in the US and the EU. Credit: humpath.com humpath.com / Flickr (Creative Commons).